News

Dividend Checkup Amid Trump Drug Pricing Order: I Prefer AbbVie Over Pfizer
Evaluate AbbVie Inc. vs. Pfizer Inc. amidst tariff disputes and drug pricing policies. Click for our comparison of ABBV and ...
3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer subsidiary receives A2 rating from Moody’s with stable outlook
Investing.com -- Moody’s Ratings has assigned an A2 rating to Pfizer Netherlands International Finance B.V. (PNIF BV), a ...
HotCopper on MSN23h
Could this ASX stock become the next Pfizer? A look at AFT Pharmaceuticals
With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for ...
EU court annuls rejection of bid for EU's von der Leyen vaccine messages with Pfizer
Europe's second-top court on Wednesday dismissed the European Commission's rejection of a New York Times' request to access text messages between its President Ursula von der Leyen and Pfizer CEO ...
MarketWatch23h
World Markets
The latest headlines from Newswires.
Investing Snacks14h
Pfizer Slims Its Wallet, Terns Tries to Fly Anyway
BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...